Quality by design approach to understand the process of nanosuspension preparation.
about
Organic Solvent-Free, One-Step Engineering of Graphene-Based Magnetic-Responsive Hybrids Using Design of Experiment-Driven MechanochemistryPreclinical studies of N₃-O-toluyl-fluorouracil-loaded lipid-based nanosuspensions in H₂₂-bearing mice.Utilizing quantitative certificate of analysis data to assess the amount of excipient lot-to-lot variability sampled during drug product development.Functionality of disintegrants and their mixtures in enabling fast disintegration of tablets by a quality by design approachEffects of homogenization process parameters on physicochemical properties of astaxanthin nanodispersions prepared using a solvent-diffusion technique.Nanosuspension: An approach to enhance solubility of drugsPhysical-chemical properties of furosemide nanocrystals developed using rotation revolution mixer.Formulation optimization of Docetaxel loaded self-emulsifying drug delivery system to enhance bioavailability and anti-tumor activity.Statistical modeling methods to analyze the impacts of multiunit process variability on critical quality attributes of Chinese herbal medicine tablets.Developing oral drug delivery systems using formulation by design: vital precepts, retrospect and prospects.A mini review of nanosuspensions development.Investigation of design space for freeze-drying: use of modeling for primary drying segment of a freeze-drying cycle.Solidification of nanosuspensions for the production of solid oral dosage forms and inhalable dry powders.A recent trend of drug-nanoparticles in suspension for the application in drug delivery.Application of quality by design to the development of analytical separation methods.A Design of Experiment Study of Nanoprecipitation and Nano Spray Drying as Processes to Prepare PLGA Nano- and Microparticles with Defined Sizes and Size Distributions.Enhancement of solubility of poorly water soluble anti hypertensive drug by nanosizing approach.Quality by design: screening of critical variables and formulation optimization of Eudragit E nanoparticles containing dutasteride.Identification of critical process parameters and its interplay with nanosuspension formulation prepared by top down media milling technology--a QbD perspective.Osmotically controlled pulsatile release capsule of montelukast sodium for chronotherapy: statistical optimization, in vitro and in vivo evaluation.Taste-masked tacrolimus-phospholipid nanodispersions: dissolution enhancement, taste masking and reduced gastric complications.Enhanced oral bioavailability of the antiretroviral efavirenz encapsulated in poly(epsilon-caprolactone) nanoparticles by a spray-drying method.Design and in vitro characterization of ivermectin nanocrystals liquid formulation based on a top-down approach."Vitamin E" fortified parenteral lipid emulsions: Plackett-Burman screening of primary process and composition parameters.Development of hydroxyapatite-ciprofloxacin bone-implants using "Quality by design".Development, optimization and in vivo characterization of domperidone-controlled release hot-melt-extruded films for buccal delivery.Application of quality by design for 3D printed bone prostheses and scaffolds.Pharmacokinetic and pharmacodynamic studies of nisoldipine-loaded solid lipid nanoparticles developed by central composite design.Media milling process optimization for manufacture of drug nanoparticles using design of experiments (DOE).Development of olmesartan medoxomil optimized nanosuspension using the Box-Behnken design to improve oral bioavailability.Nanomedicine: Principles, Properties, and Regulatory IssuesOptimization of protein loaded PLGA nanoparticle manufacturing parameters following a quality-by-design approach
P2860
Q30976100-EB809E48-1909-4672-9AE0-0B6CE68FE420Q33709579-23DE1746-869B-4D43-A406-6740C9CC2FD8Q34005835-136B17FE-F994-49A3-88AC-845CB537A882Q34265134-AC6DD9E1-3F83-497F-842C-A3952E06E3DCQ35082004-40548BE8-F9A1-4F8A-A172-6DACD2789CF2Q35554511-AAFF48A0-FE94-4C79-AC8C-39756AD04236Q36185904-05E92D16-BDA3-4B0E-9F5E-7C19B055C636Q36949647-69019FCC-B91F-4BBC-AFA1-A395710D4A90Q37468645-97AA5EAF-505F-4F99-80E5-9CDC1F596162Q37905839-A56678EF-C198-4C7A-BEAE-0EA3E91A3B19Q37970772-094D4DBA-A024-4C0A-9414-9719BEB6A839Q38312299-DA497DF0-F8F7-4459-9FD6-18E5AB5B7AF4Q38696042-529808D7-5FDE-4C10-96F5-57B568089938Q38985268-49018873-97B1-419E-8DB9-7DE487C724BCQ39559677-3696DA54-4C24-41B2-BB40-032F9F4A7041Q41486630-FCCA8DF5-343E-4583-B7A0-A022972BEC8CQ42432189-1BA38C95-602D-440E-9B25-0A60B390621DQ43978588-C2B428B0-4B5A-4D94-B051-EE4C13EC1DCCQ44708632-DD419D3D-CD33-4721-A911-7343836FE507Q45336770-79D0C353-F092-4639-AC95-E97F6DFBC223Q46799710-DD7F3703-7DC0-4B6A-BB53-F30A04A77958Q46907206-546EFC77-6A3B-4E79-B1A9-EC66B66A9E00Q48185022-3FAAC474-FF5A-4275-A05A-B15534A6AEC6Q51372186-B8DB9343-7B2B-4256-8B0D-E51D03127D51Q51591631-94FE9387-646E-4795-8C76-A8C3830D2E6BQ51660419-0834C080-38B7-4359-93A5-83C87A630CBDQ52591838-66ADE309-A9B0-4495-822B-FDC17733D02FQ53561856-9C8F884E-55DD-47BF-9EE2-ED1B117CA132Q53679419-05DD2249-89F5-4A7D-BD0C-029221EE567CQ53769446-873EF81D-A994-477B-ADF1-D6EA04D7E9C9Q57168448-4596091D-383B-4E3D-B6B0-1C13974E8CB0Q57656129-496B8E95-2CA5-4D8F-9337-1E7236C57F8D
P2860
Quality by design approach to understand the process of nanosuspension preparation.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Quality by design approach to understand the process of nanosuspension preparation.
@ast
Quality by design approach to understand the process of nanosuspension preparation.
@en
type
label
Quality by design approach to understand the process of nanosuspension preparation.
@ast
Quality by design approach to understand the process of nanosuspension preparation.
@en
prefLabel
Quality by design approach to understand the process of nanosuspension preparation.
@ast
Quality by design approach to understand the process of nanosuspension preparation.
@en
P2093
P1476
Quality by design approach to understand the process of nanosuspension preparation.
@en
P2093
Diane J Burgess
Rajeev Gokhale
Sudhir Verma
P304
P356
10.1016/J.IJPHARM.2009.05.006
P407
P577
2009-05-14T00:00:00Z